STOCK TITAN

Vivo funds disclose DBV Technologies (DBVT) stakes totaling 5.7% and 0.7%

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

DBV Technologies S.A. (DBVT) received an updated ownership report on its ordinary shares, represented by American Depositary Shares. Vivo Opportunity Fund Holdings, L.P. and its general partner Vivo Opportunity, LLC report beneficial ownership of 15,685,950 ordinary shares, or 5.7% of the class, based on 274,852,082 ordinary shares outstanding as of February 9, 2026.

Separately, Vivo Opportunity Cayman Fund, L.P. and its general partner Vivo Opportunity Cayman, LLC report beneficial ownership of 2,014,280 ordinary shares, or 0.7% of the class. The filing states the securities are not held for the purpose of changing or influencing control of DBV Technologies.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The reported ordinary shares, nominal value 0.10 euro per share (the "Ordinary Shares") of DBV Technologies S.A. (the "Issuer"), represented by 3,137,190 American Depository Shares ("ADSs"), are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. The percentage is calculated based on 274,852,082 Ordinary Shares outstanding of the Issuer as of February 9, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The reported Ordinary Shares of the Issuer, represented by 3,137,190 ADSs, are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. The percentage is calculated based on 274,852,082 Ordinary Shares outstanding of the Issuer as of February 9, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The reported Ordinary Shares of the Issuer, represented by 402,856 ADSs, are held of record by Vivo Opportunity Cayman Fund, L.P. Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P. The percentage is calculated based on 274,852,082 Ordinary Shares outstanding of the Issuer as of February 9, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The reported Ordinary Shares of the Issuer, represented by 402,856 ADSs, are held of record by Vivo Opportunity Cayman Fund, L.P. Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P. The percentage is calculated based on 274,852,082 Ordinary Shares outstanding of the Issuer as of February 9, 2026.


SCHEDULE 13G



Vivo Opportunity Fund Holdings, L.P.
Signature:/s/ Kevin Dai
Name/Title:Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Date:02/13/2026
Vivo Opportunity, LLC
Signature:/s/ Kevin Dai
Name/Title:Kevin Dai/Managing Member
Date:02/13/2026
Vivo Opportunity Cayman Fund, L.P.
Signature:/s/ Kevin Dai
Name/Title:Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner
Date:02/13/2026
Vivo Opportunity Cayman, LLC
Signature:/s/ Kevin Dai
Name/Title:Kevin Dai/Managing Member
Date:02/13/2026

FAQ

What ownership stake does Vivo Opportunity report in DBV Technologies (DBVT)?

Vivo Opportunity Fund Holdings, L.P. and its general partner Vivo Opportunity, LLC report beneficial ownership of 15,685,950 ordinary shares, equal to 5.7% of DBV Technologies’ outstanding ordinary shares, based on 274,852,082 ordinary shares outstanding as of February 9, 2026.

How many DBV Technologies shares does Vivo Opportunity Cayman hold?

Vivo Opportunity Cayman Fund, L.P. and its general partner Vivo Opportunity Cayman, LLC report beneficial ownership of 2,014,280 ordinary shares of DBV Technologies, representing 0.7% of the outstanding ordinary shares, calculated using the same 274,852,082-share base as of February 9, 2026.

How are DBV Technologies (DBVT) shares held by the Vivo Opportunity entities structured?

The reported DBV Technologies ordinary shares are represented by American Depositary Shares (ADSs). For Vivo Opportunity Fund Holdings, L.P., 15,685,950 ordinary shares correspond to 3,137,190 ADSs, while 2,014,280 ordinary shares for the Cayman fund correspond to 402,856 ADSs.

Are the Vivo Opportunity stakes in DBV Technologies intended to influence control?

The filing certifies the securities were not acquired and are not held for the purpose of changing or influencing control of DBV Technologies and are not held in connection with any transaction having that purpose, other than activities related to a nomination under the specified SEC rule.

Who ultimately controls the Vivo Opportunity holdings in DBV Technologies (DBVT)?

DBV Technologies shares are held of record by Vivo Opportunity Fund Holdings, L.P. and Vivo Opportunity Cayman Fund, L.P.. Their respective general partners, Vivo Opportunity, LLC and Vivo Opportunity Cayman, LLC, may be deemed to beneficially own the same ordinary shares and associated ADSs.

What is the date of the DBV Technologies ownership event reported by Vivo Opportunity?

The Schedule 13G/A amendment identifies the relevant event date as January 12, 2026. Ownership percentages are calculated using 274,852,082 DBV Technologies ordinary shares outstanding as of February 9, 2026, as stated in the disclosure.
Dbv Technologies S A

NASDAQ:DBVT

DBVT Rankings

DBVT Latest News

DBVT Latest SEC Filings

DBVT Stock Data

1.19B
50.80M
5.3%
0.07%
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
France
CHATILLON